Research by a team of neuroscientists from the University of Nevada, Las Vegas has shown that it is possible to identify the molecular mechanisms underlying a host of adverse symptoms associated with unique subtypes of neurodevelopmental disorders. This work could one day improve the lives of millions of people worldwide.

Psychedelic drugs such as psilocybin, LSD and mescaline are illegal in most of the country, considered Class 1 drugs by the federal government.

Science is one step closer to developing targeted drug therapies that may reduce seizures, sleep disorders, and related symptoms common in people with intellectual disabilities.

Science is getting one step closer to developing drug therapies that may reduce seizures, sleep disorders, and related symptoms common in people with intellectual disabilities.

Science is getting one step closer to developing drug therapies that may reduce seizures, sleep disorders, and related symptoms common in people with intellectual disabilities.

Science is one step closer to developing targeted drug therapies that may reduce seizures, sleep disorders, and related symptoms common in people with intellectual disabilities.

Thousands suffering from epilepsy have been given new hope as a new breakthrough brings scientists one step closer to being able to "turn off" epileptic seizures.

Science is a step towards developing targeted drug therapies that can reduce seizures, sleep disturbances and related symptoms common in people with intellectual disabilities.